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s u m m a r y 
Objectives: The magnitude of impact caused by low blood culture utilization on estimates of the propor- 
tions and incidence rates of antimicrobial-resistant (AMR) bacterial infections is largely unknown. 
Methods: We used routine electronic databases of microbiology, hospital admission and drug prescription 
at Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand, from 2011 to 2015, and bootstrap simulations. 
Results: The proportions of Escherichia coli and Klebsiella pneumoniae bacteraemias caused by 3rd gen- 
eration cephalosporin resistant isolates (3GCREC and 3GCRKP) were estimated to increase by 13 and 
24 percentage points (from 44% to 57% and from 51% to 75%), respectively, if blood culture utilization 
rate was reduced from 82 to 26 blood culture specimens per 1,0 0 0 patient-days. Among patients with 
hospital-origin bloodstream infections, the proportion of 3GCREC and 3GCRKP whose first positive blood 
culture was taken within ±1 calendar day of the start of a parenteral antibiotic at the study hospital was 
substantially lower than those whose first positive blood culture was taken later into parenteral antibi- 
otic treatment (30% versus 79%, p < 0.001; and 37% versus 86%, p < 0.001). Similar effects were observed 
for methicillin-resistant Staphylococcus aureus , carbapenem-resistant Acinetobacter spp. and carbapenem- 
resistant Pseudomonas aeruginosa . 
Conclusion: Impacts of low blood culture utilization rate on the estimated proportions and incidence 
rates of AMR infections could be high. We recommend that AMR surveillance reports should addition- 
ally include blood culture utilization rate and stratification by exposure to a parenteral antibiotic at the 
hospital. 
© 2020 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 


















Antimicrobial-resistance (AMR) surveillance reports are com- 
only used to monitor trends, inform recommendations for em- 
irical therapy, estimate the burden of AMR, and assess the im- 
act of local, national and global interventions. 1–3 Such reports ∗ Corresponding authors at: Mahidol Oxford Tropical Medicine Research Unit, Fac- 
lty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, 
hailand. 
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ty specimens, particularly from blood, that have been taken for 
linical purposes. 1 , 4 The reports are also commonly referred to as 
umulative antibiogram reports and cumulative antimicrobial sus- 
eptibility reports. 5 In 2015, the World Health Organization (WHO) 
aunched the Global Antimicrobial Resistance Surveillance System 
GLASS), promoting the use of globally agreed and standardized 
ethods for compiling and reporting data locally and nationally. 1 
he recommended standardization includes how data should be 
e-duplicated and how to use specimen collection and hospital ad- 
ission dates to classify the origin of infection into community- 
r hospital-origin as a proxy for community- or hospital-acquired ion Association. This is an open access article under the CC BY license 
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nfection, respectively. Estimated parameters include the propor- 
ions of patients with bloodstream infection (BSI) caused by AMR 
solates (using an isolate-based surveillance approach), and inci- 
ence rates of patients with bloodstream infection (BSI) caused 
y AMR isolates in the tested population (using a sample-based 
urveillance approach) stratified by origin of infection (community 
r hospital). 1 
It is well recognised that a low blood culture utilization rate 
an bias AMR surveillance data, 1 , 4 , 6 but the magnitude of impact 
rom this on estimates of proportions and incidence rates of AMR 
nfections is largely unknown. 7 In hospitals in low and middle- 
ncome countries (LMICs), patients with severe infectious diseases 
re frequently treated empirically and blood culture is frequently 
ampled after empirical treatment failure. Here, we quantify the 
agnitude of effect caused by low blood culture utilization rates 
n LMICs on estimates of proportions and incidence rates of AMR 
nfections. We also develop and evaluate a new parameter to rep- 
esent blood culture utilization in LMICs. 
aterials and methods 
tudy design 
We conducted a simulation study using the routine electronic 
atabases of microbiology, hospital admission and drug prescrip- 
ion at Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand, 
rom 2011 to 2015. Ethical permission for this study was obtained 
rom the Oxford Tropical Research Ethics Committee (Ref. 557- 
7), and the ethical committee of Sunpasitthiprasong Hospital (Ref. 
05/2560). The committees waived the requirement to obtain indi- 
idual informed consent due to the study design and minimal risk 
o the subjects. 
efinitions 
We used the definitions of infection origin as proposed by WHO 
LASS. 1 In brief, community-origin (or hospital-origin) BSI was 
efined for patients in the hospital within (or longer than) the 
rst two calendar days of admission when the first blood speci- 
ens culture positive for a pathogen were taken. 1 A blood culture 
pisode was defined as all blood culture specimens taken within 
wo calendar days beginning when a blood culture specimen was 
aken. 
We focused on rates of blood culture utilization in relation to 
SI caused by Escherichia coli, Klebsiella pneumoniae, Staphylococ- 
us aureus, Acinetobacter spp. and Pseudomonas aeruginosa because 
hese are the top five pathogens attributable to deaths caused by 
MR infections in Thailand 8 and the EU and the European Eco- 
omic Area. 9 
Proportions of 3rd generation cephalosporin resistant E. coli 
3GCREC) and K. pneumoniae (3GCRKP), methicillin-resistant S. au- 
eus (MRSA), and carbapenem-resistant Acinetobacter spp. (CRACI) 
nd P. aeruginosa (CRPA) were defined as the ratio of the number 
f patients having a blood culture positive for 3GCREC, 3GCRKP, 
RSA, CRACI and CRPA, and the total number of patients with at 
east one positive blood culture with the given organism, respec- 
ively. Only the first isolate per patient, per pathogen, per study 
eriod was included in the analyses. Supplementary text describes 
ow all parameters were estimated. 1 , 10 
We developed a new variable ‘proportion of patients having a 
lood culture taken within ±1 calendar day of the day when a 
arenteral antibiotic was started and continued for at least four 
onsecutive days.’ We included patients who died, were discharged 
o a hospice or transferred to another hospital before completing 
our consecutive days of antibiotics and had antibiotics continu- 
usly until the day prior to death, a hospice discharge or trans- 2 er, respectively. 11 We included consecutive calendar days with any 
arenteral antibiotics after a parenteral antibiotic was started. We 
sed four consecutive days of parenteral antibiotics as a proxy for 
resumed severe infection, 11 in which blood culture is generally 
ecommended. 12 , 13 
tatistical analysis 
We used bootstrap resampling with 200 iterations for each sim- 
lation. The median and the 2.5th and 97.5th percentiles are pre- 
ented. To quantify the potential magnitude of impact caused by 
ow blood culture utilization rate in LMICs, we simulated datasets 
n which only 50%, 25% and 10% of all first blood culture episodes 
ere included using data from the patients with blood cultures 
nd bootstrap simulations. We included in the analyses our data 
rom all repeated blood culture episodes to represent delayed 
lood culture if the first blood culture episodes were not sam- 
led. Proportions were compared between groups using Chi-square 
est or Fisher’s Exact test. Continuous variables were compared 
etween groups using Kruskal–Wallis test. All analyses were per- 
ormed using STATA 14.2 (StataCorp LP, College Station, Texas). 
esults 
aseline characteristics 
Of 313,661 patients admitted to the study hospital from 2011 
o 2015, 81,036 patients had at least one blood culture taken 
total 242,098 blood cultures) ( Table 1 and Fig. 1 ). Total patient 
ays were 2,956,643, giving a blood culture utilization rate of 82 
lood cultures per 1,0 0 0 patient-days. Around three quarters of 
atients (62,756 of 81,036 cases, 77%) had a single blood culture 
pisode during their admission (defined as all blood cultures col- 
ected within two calendar days from the first specimen). 11,410 
14%), 3,751 (5%), 1,538 (2%) and 1,581 (2%) patients had two, three, 
our and at least five blood culture episodes during their admis- 
ions, respectively. Among patients who had repeated blood cul- 
ure episodes, the median time between the first and second blood 
ulture episode was 5 calendar days (IQR, 3–9 days). 
We identified 1,959, 1,045, 1,092, 1,0 0 0 and 450 patients with 
lood cultures positive for E. coli, K. pneumoniae, S. aureus, Acine- 
obacter spp. and P. aeruginosa , respectively. The proportions of 
GCREC, 3GCRKP, MRSA, CRACI and CRPA were 44%, 51%, 23%, 
5% and 28% respectively ( Table 2 ). The proportions of 3GCREC, 
GCRKP, MRSA, CRACI and CRPA in BSI of hospital-origin were 
ignificantly higher than those in BSI of community-origin (all 
 < 0.001, Table 2 ). Estimated incidence rates of 3GCREC, 3GCRKP, 
RSA, CRACI and CRPA BSI per 10 0,0 0 0 population per year were 
.5, 5.8, 2.7, 7.0 and 1.4, respectively (Tables S1–S5). Using a 
ample-based approach proposed by WHO GLASS, we estimated 
ncidence rates for 3GCREC, 3GCRKP MRSA, CRACI and CRPA BSI 
er 10 0,0 0 0 tested patients of 1,071, 659, 311, 798 and 154, respec-
ively. 
187,302 patients (60%) received at least one parenteral antibi- 
tic (Fig. S1). The most common agents in use being ceftriax- 
ne (346,167 patient-days), carbapenem drugs (253,466 patient- 
ays) and ceftazidime (251,548 patient-days). The proportion of 
atients who had a blood culture taken within ±1 calendar day 
f the start of parenteral antibiotic treatment that was then con- 
inued for at least four consecutive days was 44% (47,132/106,341). 
his rate was higher in patients who began a parenteral an- 
ibiotic within the first two calendar days of hospital admis- 
ion (46%; 41,4 89/90,6 85) compared with after two calendar days 
36%; 5643/15,656; p < 0.001). This rate was also higher in pa- 
ients first admitted to internal medicine or pediatric wards (80%; 
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Table 1. 
Baseline characteristics of the study population in Sunpasitthiprasong Hospital. 
General parameters for the hospital and from hospital admission data file Sunpasitthiprasong Hospital, Thailand from 2011 to 2015 (5 years) 
Hospital bed capacity (beds) 1,183 beds (in 2015) 
Total number of inhabitants in the catchment area 1,844,669 population (in 2015) 
Total number of admission records 484,227 admissions 
Total number of admission records with in-hospital mortality outcome 15,589 admissions 
Total number of patient-days (up to 31Dec2015) 2,956,643 patient-days 
Total number of inpatients (de-duplicated patients) 313,661 patients 
General parameters from microbiology laboratory data file 
Number of blood culture specimens 242,098 samples 
Number of blood culture results recorded as “no growth” 216,558 samples (89%) 
Number of patients sampled for blood culture (de-duplicated patients) 81,036 patients 
General parameters from drug prescription data file 
Number of parenteral antibiotic records 590,922 records 
Number of patient-days with a parenteral antibiotic (de-duplicated patient-days) ∗ 1,456,027 patient-days 
Number of patients prescribed with a parenteral antibiotic (de-duplicated patients) 187,302 patients 
∗ If a patient had more than one parenteral antibiotic on a given day, the number was counted as one patient-day with a parenteral antibiotic. 
Fig. 1.. Study data flow diagram. ∗ A blood culture episode was defined as all blood culture specimens collected within two calendar days beginning when a blood culture 
specimen was collected. 
Table 2. 
Proportions of patients with blood cultures positive for antibiotic-resistant isolates for five bacterial species. 
Species Resistance of interest 
Proportion with specified resistance 
P value Total BSI of community-origin ∗ BSI of hospital-origin ∗
Escherichia coli Third-generation cephalosporin resistance 
(3GCREC) 
44% (868/1,959 patients) 42% (631/1,514 patients) 53% (237/445 patients) < 0.001 
Klebsiella pneumoniae Third-generation cephalosporin resistance 
(3GCRKP) 
51% (534/1,045 patients) 34% (193/569 patients) 72% (341/476 patients) < 0.001 
Staphylococcus aureus Methicillin resistance (MRSA) 23% (252/1,092 patients) 14% (103/750 patients) 44% (149/342 patients) < 0.001 
Acinetobacter spp Carbapenem resistance (CRACI) 65% (647/1,000 patients) 33% (80/242 patients) 75% (567/758 patients) < 0.001 
Pseudomonas aeruginosa Carbapenem resistance (CRPA) 28% (125/450 patients) 14% (23/170 patients) 36% (102/280 patients) < 0.001 
∗ Blood stream infection (BSI) of community-origin was defined as patients in hospital for ≤2 calendar days when the first blood-culture positive for the pathogen was 
taken, and BSI of hospital-origin was defined as patients admitted for > 2 calendar days when the first blood-culture positive for pathogen was taken 1 . Only the first isolate 
per patient, per pathogen, per study period was included in the analysis. 
3 
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Fig. 2.. Diagrams illustrating how AMR surveillance data could be influenced if blood culture is delayed or not performed. Green and red blocks indicate the non-infectious 
and infectious patient state, respectively. B/C and ATB indicate blood culture collection date and the date receiving a parenteral antibiotic, respectively. Patients A and B 
have BSI of community-origin and hospital-origin, respectively, which could be detected through appropriate blood culture sampling within ±1 calendar day of the start of 
a parenteral antibiotic. Patients C and D have BSI of community-origin who are either not cultured at all and so data points will be missing (C), or have delayed culture that 
results in errors caused by exposure to ATB and incorrect assignment of a positive culture result as BSI of hospital-origin (D). Patients E and F have BSI of hospital-origin 









































8,820/48,579) versus other wards including surgery and orthope- 
ics (14%; 8312/57,762, p < 0.001). 
mpact of incorrect blood culture practice on estimated proportions of 
MR infections 
Estimates of the proportions of AMR infection in a given pop- 
lation could be influenced by variation in blood culture practice, 
pecifically when samples are not systematically taken in relation 
o the time of presentation with features of infection and com- 
encement of antibiotic treatment. Fig. 2 provides a descriptive 
ramework based on six possible scenarios where patients are ei- 
her correctly (cases A & B) or incorrectly sampled (cases C to F), 
ogether with the effect of incorrect sampling on data generated 
or the proportions of AMR infection. 
In bootstrap simulations, the proportion of 3GCREC was esti- 
ated to increase by 13 percentage points (from 44% to 57%) if 
nly 10% of the first blood culture episodes were sampled ( Fig. 3 ,
ow 1). The most probable proportion of 3GCREC in patients with 
SI of community-origin (42%) would not change, but the propor- 
ion could range from 36% to 48% due to lower sample sizes as 
hown by its 95% bootstrap confidence intervals (BCI 36–48%). The 
stimated proportion of 3GCREC in patients with BSI of hospital- 
rigin would increase by 17 percentage points (from 53% to 70%). 4 imilar effects were observed for 3GCRKP , MRSA, CRACI and CRPA 
Figs. S2–S5). 
mpact of incorrect blood culture practice on estimated AMR rates 
The rate of AMR infections per 10 0,0 0 0 population per year is 
ommonly used to estimate and monitor burden of AMR infec- 
ions, 2 , 3 and was estimated in our simulations. The incidence rate 
f patients with 3GCREC BSI per 10 0,0 0 0 population per year was 
stimated to decrease by 75% (from 9.5 to 2.4; Fig. 3 , row 2) if 10%
f the first blood culture episode were sampled. This was because 
he number of patients with 3GCREC BSI identified (numerator for 
he incidence rate) would decrease from 868 cases to 224 (95% BCI 
11–241; Table S1), while the total population coverage (denom- 
nator for the incidence rate) was constant. The decrease in the 
stimated incidence rate of community-origin 3GCREC per 10 0,0 0 0 
opulation (from 6.9 to 0.8) was considerably higher than that for 
ospital-origin 3GCREC (from 2.6 to 1.7). Similar effects were ob- 
erved for 3GCRKP , MRSA, CRACI and CRPA (Figs. S2–S5). 
The incidence rate of 3GCREC BSI per 10 0,0 0 0 tested patients 
as estimated to decrease by 20% (from 1,071 to 890; Fig. 3 , row
) if 10% of the first blood culture episodes were sampled. How- 
ver, the incidence rate of 3GCRKP, MRSA, CRACI and CRPA BSI per 
0 0,0 0 0 tested patients were estimated to increase by 71% (from 
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Fig. 3.. Estimated proportions and incidence rates of 3rd generation cephalosporin resistant E. coli (3GCREC) if 50%, 25% and 10% of the first blood culture episodes ∗ were 


























59 to 1,128), 108% (from 311 to 648), 147% (from 798 to 1,975) 
nd 132% (154 to 358) respectively (Tables S2–S5). 
mpact of incorrect blood culture practice on parameters representing 
lood culture utilization 
Blood culture utilization rate per 1,0 0 0 patient-days is com- 
only used to represent the practice of blood culture sampling 
nd was estimated in our simulations. The utilization rate was es- 
imated to decrease from 82 to 26 per 1,0 0 0 patient days if 10% of
he first blood culture episodes were sampled ( Fig. 3 row 4). How- 
ver, this parameter could not be stratified by origin of infection. 
The proportion of patients having a blood culture taken within 
1 calendar day of the day when a parenteral antibiotic was 
tarted and continued for at least four consecutive days would 
lso correspondingly reduce from 44% to 6% if 10% of the first 5 lood culture episodes were sampled ( Fig. 3 , row 5). The parame- 
er could be stratified by origin of infection. In our simulations, the 
ecline was greater among patients at risk of BSI of community- 
rigin (from 46% to 5%) than that of hospital-origin (from 36% 
o 11%). 
roportions of AMR infections stratified by exposure to a parenteral 
ntibiotic 
We stratified patients with BSI of hospital-origin by exposure 
o a parenteral antibiotic at the study hospital ( Fig. 4 ). The propor-
ion of 3GCREC in patients whose first positive blood culture was 
aken within ±1 calendar day of the start of a parenteral antibiotic 
as substantially lower compared with patients whose first posi- 
ive blood culture was taken later into parenteral antibiotic treat- 
ent (30% versus 79%, p < 0.001). The median duration of hospital 
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Fig. 4.. Proportions of 3GCEC, 3GCRKP, MRSA, CRACI and CRPA in patients with BSI of hospital-origin stratified by exposure to a parenteral antibiotic at the study hospital 
and if 50%, 25% and 10% of the first blood culture episodes ∗ were sampled. ∗ A blood culture episode was defined as all blood culture specimens collected within two 













dmission in the former group was around half that of the latter 
roup (5 vs. 10.5 days, p < 0.001, Table S6). The median duration of 
xposure to a parenteral antibiotic at the study hospital in the for- 
er group was significantly lower than that of the latter group was 
0 vs. 7.5 days, p < 0.001, Table S6). Similar effects were observed for 
GCKP, MRSA, CRACI and CRPA ( Fig. 4 ). 6 We also explored whether (a) the large difference between the 
roportion of AMR infections from blood cultures taken within ±1 
alendar day of the start of a parenteral antibiotic versus the pro- 
ortion of AMR infections from blood cultures taken later, and (b) 
he low proportion of AMR infections from blood cultures taken 
ithin ±1 calendar day of the start of a parenteral antibiotic would 
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till be observed when blood culture was often delayed. We found 
hat the large difference between the proportion of 3GCREC from 
lood cultures taken within ±1 calendar day of the start of a par- 
nteral antibiotic versus the proportion of 3GCREC from blood cul- 
ures taken later was estimated to be present even if 10% of the 
rst blood culture episodes were sampled. The most probable pro- 
ortion of 3GCREC from blood culture taken ±1 calendar day of 
he start of a parenteral antibiotic was estimated to decrease by 4 
ercentage point (from 30% to 26%; Fig. 4 row 1). 
The large difference between proportions of 3GCRKP, MRSA and 
RACI from blood cultures taken within ±1 calendar day of the 
tart of a parenteral antibiotic versus the corresponding propor- 
ions from blood cultures taken later was also estimated to be 
resent if 10% of the first blood culture episodes were sampled 
 Fig. 4 ). The most probable proportions of 3GCRKP, MRSA, CRACI 
nd CRPA in patients whose first positive blood culture was taken 
ithin ±1 calendar day of the start of a parenteral antibiotic were 
stimated to increase by 17 percentage points (from 37 to 54%), 
 percentage points (from 9 to 14%), 13 percentage points (32 to 
5%) and 26 percentage points (from 12 to 38%), if 10% of the first 
lood culture episodes were sampled (Tables S7–S10). 
iscussion 
We illustrate that estimates of the proportions and incidence 
ates of AMR infections could be considerably changed due to low 
lood culture utilization rates in LMIC settings, where patients are 
requently treated empirically and blood culture is frequently sam- 
led after empirical treatment failure. This could occur even if 
here are no changes in true susceptibility profiles of pathogenic 
rganisms and in true infection rates in that environment. We 
how that the proportions of 3GCREC, 3GCRKP, MRSA, CRACI and 
RPA could rise by 13, 24, 20, 16 and 15 percentage points if 
lood culture utilization rate was reduced from 82 to 26 per 1,0 0 0 
atient days. The incidence rates of AMR infections per 10 0,0 0 0 
opulation per year could fall considerably. However, the changes 
n incidence rates of AMR infections per 10 0,0 0 0 tested patients 
ould vary by organism, ranging from a 20% decrease for 3GCREC 
o a 147% increase for CRACI. We also show that the proportions 
f AMR isolates from blood sampled within ±1 calendar day were 
ignificantly lower than those from blood sampled outside ±1 cal- 
ndar day when a parenteral antibiotic was started at the study 
ospital. 
Multiple reasons could contribute to the increase of total pro- 
ortions of AMR infections if blood culture is frequently de- 
ayed. First, the decrease in total numbers of patients with BSI of 
ommunity-origin is more than the decrease in those with BSI of 
ospital-origin (Tables S1–S5). The former has lower proportions of 
MR infections compared to the latter and so the total proportions 
f AMR infections increase. Second, the proportions of AMR infec- 
ions in patients with BSI of hospital-origin increase. This could 
e because longer hospital stays and prior exposure to parenteral 
ntibiotics can increase the risk of AMR infections, 14 , 15 profiles 
f pathogenic organisms from patients with BSI of hospital-origin 
ho improve after empirical treatment are missing (the scenario 
f Patient E in Fig. 2 ), and prior exposure to parenteral antibiotics 
an also reduce an opportunity to detect non-AMR bacteria from 
atients with non-AMR infections 16 (the scenario of Patient F in 
ig. 2 ). 
Blood culture utilization rate and the new parameter (the pro- 
ortion of patients having a blood culture taken within ±1 calen- 
ar day of the day when a parenteral antibiotic was started at the 
tudy hospital and continued for at least four consecutive days) 
erformed well in our simulations. They correlated well with the 
eduction of blood culture sampling in bootstrap simulations. The 
ew parameter is also useful to understand blood-culturing prac- 7 ices in different settings (e.g. with different origin of infection and 
n different wards). 
High blood culture utilization rate in Thailand, a middle-income 
ountry, is consistent with our previous finding that the total num- 
er of blood culture bottles used at the study hospital had been 
ising from 5,235 bottles per year in 1995 to 56,719 bottles per 
ear in 2015. 17 A high proportion of patients having blood culture 
ampled within ±1 calendar day of the day when a parenteral an- 
ibiotic was started (80%) in internal medicine and pediatric wards 
s supported by a previous prospective observational study. 18 In 
outine care at the study hospital, 84% of adult patients present- 
ng with sepsis in internal medicine wards had a blood culture 
pecimen collected and 89% received parenteral antibiotics within 
he first two calendar day of hospital admission. 18 Blood culture 
tilization rate at the study hospital (82 blood culture specimens 
er 1,0 0 0 patient-days) is within the range of the number of blood 
ulture sets tested per 1,0 0 0 patient-days reported in the Europe 
anging from 6.7 in Latvia to 86.5 in France. 9 
imitations 
Our study has several limitations. First, the magnitude of impact 
hown may not be generalizable to other settings. Second, the defi- 
ition of origin of infection is only a proxy for community-acquired 
nd hospital-acquired infection. 1 A proportion of patients with BSI 
f community-origin could be caused by nosocomial infections ac- 
uired at transferring hospitals. 19 Third, our data could not define 
hether two or more blood cultures obtained on the same day 
ere drawn from a single phlebotomy (in which those specimens 
ould be defined as a single blood culture set). 9 , 20 , 21 Therefore, 
e reported blood cultures per 10 0 0 patient-days, which is prob- 
bly higher than the value of blood culture sets per 10 0 0 patient- 
ays. 9 , 20 Fourth, we could not determine the impact caused by ex- 
osure to a parenteral antibiotic prior to hospital admission. Fifth, 
e could not determine why the proportion of patients having a 
lood culture taken within ±1 calendar day of the day when a par- 
nteral antibiotic was started is low in the wards other than pedi- 
tric and internal medicine wards. This could be due to high pro- 
ortion of contaminated and dirty procedures (e.g. open, fresh, ac- 
idental wounds), continuing antimicrobial prophylaxis after clean 
nd clean-contaminated procedures (which is currently not recom- 
ended even in the presence of a drain), 22 , 23 or other unknown 
auses. 
ecommendations 
Based on our findings, we proposed a set of recommendations. 
irst, we support the recommendations that AMR surveillance re- 
orts should present all parameters with stratification by origin of 
nfection, 1 and with clear terminology, methodology, and numbers 
f numerators and denominators used to calculate each parame- 
er. 6 , 24 This would allow people to compare and monitor propor- 
ions and incidence rates of AMR infections from different sources 
r settings, by being aware of or taking account of potential impact 
f different definitions and methods in the future. 6 , 24 
Second, AMR surveillance reports should report parameters rep- 
esenting blood culture utilization (such as blood culture utiliza- 
ion rates 9 , 20 and the proportion of patients having a blood culture 
aken within ±1 calendar day of the day when a parenteral antibi- 
tic was started at the study hospital and continued for at least 
our consecutive days). This is because the impact caused by low 
lood culture utilization could be high. 
Third, incidence rates per 10 0,0 0 0 tested patients should be es- 
imated and reported, especially in LMICs where blood culture uti- 
ization rate is low or unknown. 17 , 25 , 26 This is because the magni- 
ude of impact on the incidence rates per 10 0,0 0 0 tested patients 
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s likely to be lower than that on the incidence rate per 10 0,0 0 0
opulation per year if blood culture utilization rate is low ( Fig. 3 ).
he incidence rates per 10 0,0 0 0 population per year is still a good
arameter for monitoring total AMR burden in high-income coun- 
ries where blood culture utilization rates are considered high. 2 , 9 
Fourth, interpreting AMR trend needs to take account of the 
hange of blood culture utilization rate. This is because if a hos- 
ital improves their blood culture utilization rate over time (e.g. 
oubling their utilization rate), observed proportions of AMR in- 
ections could considerably decline while observed incidence rates 
f AMR infections (per 10 0,0 0 0 population per year) could consid- 
rably increase even if there are no changes in true susceptibility 
rofiles of pathogenic organisms and in true infection rates in that 
nvironment over time. 
Fifth, hospitals in LMICs with a low blood culture utilization 
ate should use AMR surveillance reports stratified by exposure 
o an empirical antibiotic at the study hospital to guide choice of 
rst-line empiric antimicrobial therapy rather than the total antibi- 
gram. This is because the cumulative antibiogram reports mainly 
ased on blood culture after failure of the first empiric treatment 
hould not be used to guide choice of the first empiric therapy. 
his is similar to the recommendations for tuberculosis, where 
roportions of multi-drug resistant tuberculosis are stratified for 
ew (never treated) tuberculosis cases and previously treated tu- 
erculosis cases, and the choice of first-line anti-tuberculosis drugs 
s based on the proportion of drug-resistant tuberculosis found in 
ew cases. 27-29 
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